JP2016519595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519595A5 JP2016519595A5 JP2016503336A JP2016503336A JP2016519595A5 JP 2016519595 A5 JP2016519595 A5 JP 2016519595A5 JP 2016503336 A JP2016503336 A JP 2016503336A JP 2016503336 A JP2016503336 A JP 2016503336A JP 2016519595 A5 JP2016519595 A5 JP 2016519595A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- brain activity
- baseline
- therapy
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 18
- 230000007177 brain activity Effects 0.000 claims 8
- 238000002560 therapeutic procedure Methods 0.000 claims 5
- 208000012902 Nervous system disease Diseases 0.000 claims 4
- 238000002582 magnetoencephalography Methods 0.000 claims 4
- 230000000638 stimulation Effects 0.000 claims 4
- 208000029560 autism spectrum disease Diseases 0.000 claims 2
- 229940000406 drug candidate Drugs 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000000763 evoking effect Effects 0.000 claims 2
- 201000001119 neuropathy Diseases 0.000 claims 2
- 230000007823 neuropathy Effects 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 150000003384 small molecules Chemical group 0.000 claims 2
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787077P | 2013-03-15 | 2013-03-15 | |
| US61/787,077 | 2013-03-15 | ||
| PCT/US2014/030138 WO2014145382A2 (en) | 2013-03-15 | 2014-03-17 | Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519595A JP2016519595A (ja) | 2016-07-07 |
| JP2016519595A5 true JP2016519595A5 (enExample) | 2017-04-27 |
| JP6585030B2 JP6585030B2 (ja) | 2019-10-02 |
Family
ID=51538466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503336A Active JP6585030B2 (ja) | 2013-03-15 | 2014-03-17 | 自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10342480B2 (enExample) |
| EP (1) | EP2967405A4 (enExample) |
| JP (1) | JP6585030B2 (enExample) |
| AU (1) | AU2014233048B2 (enExample) |
| CA (1) | CA2907494C (enExample) |
| WO (1) | WO2014145382A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018194959A1 (en) * | 2017-04-17 | 2018-10-25 | Miron Oren | Auditory brainstem response for autism prediction |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| US11426073B2 (en) * | 2018-04-27 | 2022-08-30 | Washington University | Imaging nerve function and pathologies using diffusion basis spectrum imaging |
| CN113382683A (zh) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | 改善睡眠的系统和方法 |
| US11103171B2 (en) * | 2018-10-23 | 2021-08-31 | BlackThor Therapeutics, Ine. | Systems and methods for screening, diagnosing, and stratifying patients |
| FI20185893A1 (fi) * | 2018-10-23 | 2020-04-24 | Elekta Oy | Päähän asennettava laitteisto |
| US12402828B2 (en) | 2019-03-13 | 2025-09-02 | The Children's Hospital Of Philadelphia | Methods for the detection of brain injury |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| US20220375082A1 (en) * | 2019-11-15 | 2022-11-24 | The University Of Chicago | Cancer detection based on four quadrant mapping and matrix analysis of image data |
| US12521053B2 (en) * | 2022-01-05 | 2026-01-13 | Tdk Corporation | Methods and devices for electromagnetic measurements from ear cavity |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2540295A1 (en) * | 2011-06-27 | 2013-01-02 | Centre national de la recherche scientifique | Compositions for the treatment of Fragile X syndrome |
-
2014
- 2014-03-17 EP EP14762871.3A patent/EP2967405A4/en not_active Ceased
- 2014-03-17 JP JP2016503336A patent/JP6585030B2/ja active Active
- 2014-03-17 CA CA2907494A patent/CA2907494C/en active Active
- 2014-03-17 US US14/776,168 patent/US10342480B2/en active Active
- 2014-03-17 WO PCT/US2014/030138 patent/WO2014145382A2/en not_active Ceased
- 2014-03-17 AU AU2014233048A patent/AU2014233048B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290455A (en) | Methods of treating psychological and brain disorders | |
| HUE055334T2 (hu) | Szerves vegyületek és azok alkalmazása központi idegrendszeri betegségek kezelésében vagy megelõzésében | |
| PT3545948T (pt) | Utilização de aglomerado de ouro ou substância que contém aglomerado de ouro na preparação de droga para prevenção e/ou tratamento de glaucoma | |
| IL287032A (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | |
| IL269302A (en) | Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders | |
| HUE049237T2 (hu) | Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra | |
| EA201891224A1 (ru) | Способы и системы для предоставления стимулов для головного мозга | |
| WO2016070051A3 (en) | Combination therapy for treatment of disease | |
| IL264301A (en) | Treatment of Fabry disease in ert-naive and ert-experienced patients | |
| IL246579B (en) | Compounds that inhibit the activity of 2lrrk and their use in the treatment of Parkinson's disease | |
| HUE059752T2 (hu) | A danon betegség és az autofágia egyéb rendellenességeinek kezelésére szolgáló módszerek | |
| GEP20217253B (en) | ANTIBODIES TO α-SYNUCLEIN AND USES THEREOF | |
| WO2016097315A3 (en) | Blood brain barrier transport molecules and uses thereof | |
| EP3490436A4 (en) | METHOD FOR DETECTING AND TREATING PAIN USING BRAIN ACTIVITY | |
| IL264070A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| IL269158A (en) | Compositions and methods for treating inflammatory diseases | |
| WO2017040666A3 (en) | Combination therapy for treatment of disease | |
| EP3664789A4 (en) | METHODS OF TREATMENT OF DISEASES AND NERVE INJURY | |
| IL275322A (en) | Bispecific molecules that bind 16-CD and their therapeutic use | |
| EP3517160A4 (en) | DEVICE, METHOD AND PROGRAM FOR MEMORY TRAINING BY BRAIN STIMULATION | |
| SG11202000423XA (en) | Treatment of fabry disease in ert-naïve and ert-experienced patients | |
| EP4488288A3 (en) | Means and methods for aav gene therapy in humans | |
| IL274233A (en) | Compounds, preparations and methods for the treatment of eye disorders and skin diseases | |
| Roiser | What has neuroscience ever done for us? | |
| EP3558335A4 (en) | INHIBITION OF CASPASE-1 AND ITS USES IN THE PREVENTION AND TREATMENT OF NEUROLOGICAL CONDITIONS |